Notable Labs

Personalized combination therapies for cancer patients.

News and Press

Stanford, Notable Labs and Tempus collaborate on personalized medicine research for blood cancer

MedCity News • April 15, 2019

Researchers at Stanford took blood samples from patients and sent them to Chicago-based Tempus for genomic sequencing of the person’s cancer. Another sample was sent to Notable, which used its AI-based automated laboratory system to test hundreds of potential drug treatments against the disease and provided treatment recommendations based on that analysis. Stanford clinicians then used this data (alongside the clinical features of the patient) to create a report with individualized recommendations that could inform future treatment.

Peninsula biotech's nonprofit deal spotlights unique attack on cancer in kids

San Francisco Business Times • Jan. 22, 2019

The partnership between for-profit Notable Labs and nonprofit Cures Within Reach could bring a childhood cancer treatment — a combination discovered by Foster City's Notable Labs of a generic drug and a natural product — to market faster and cheaper.

Show all News and Press (4 more)

Blog Posts

September is Blood Cancer Awareness Month

September 16, 2020

Notable Launches New Clinical Study With Washington University School of Medicine Exploring Ex Vivo Drug Screening to Predict Chemotherapy Sensitivity and Resistance

August 6, 2020

Emerging Treatment Approaches of High-Risk Myelodysplastic Syndrome

August 5, 2020

How We Capture Mechanism of Action in the Notable Platform

July 24, 2020
Show all Blog Posts (16 more)